Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
update
/
details

ISCT Achieves ANAB Accreditation for Excellence in Cell and Gene Therapy Workforce Development

NextEdge Admin

30 Sep 2024

2 min 20 sec

gene therapy,Cell Therapy,Training & Development

The ISCT Institute of Training & Development, part of the International Society for Cell and Gene Therapy (ISCT), has become the first CGT organization to achieve accreditation from the ANSI National Accreditation Board (ANAB) for excellence in workforce development. This recognition highlights ISCT’s leadership in addressing critical skill shortages in the cell and gene therapy (CGT) sector, ensuring that its courses are globally recognized and meet international standards of quality.

Awarded under the ANSI/ASTM E2659-18 standard, the accreditation validates ISCT’s commitment to high-quality training built on strong quality management systems, learner assessments, and continuous improvement. Participants in ISCT programs gain globally respected certifications, elevating their skills and credibility in the competitive CGT industry.

Queenie Jang, ISCT’s CEO, emphasized the organization's dedication to workforce development, highlighting significant investments over the past two years to bridge skill gaps through strategic global partnerships. Emily Hopewell, Co-Chair of ISCT's Workforce Development Committee, noted that the Institute collaborates with experts and partners like the NSF Engineering Research Center to develop programs addressing key industry needs.

Notable accredited courses include “Cell Product Handling and Regulatory 101” and “Essentials of Cell Therapy Product Manufacturing.” ISCT President Miguel Forte, MD, PhD, stressed that ANAB accreditation ensures that learners acquire standardized, transferable skills, crucial for both individual professional growth and advancing the CGT sector. The Institute plans to expand its offerings, with upcoming programs covering iPSCs, CAR T therapies, and advanced lab training.